WallStSmart

Docebo Inc (DCBO)vsVuzix Corp Cmn Stk (VUZI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Docebo Inc generates 4021% more annual revenue ($251.01M vs $6.09M). DCBO leads profitability with a 13.7% profit margin vs 0.0%. DCBO earns a higher WallStSmart Score of 51/100 (C-).

DCBO

Buy

51

out of 100

Grade: C-

Growth: 8.0Profit: 6.0Value: 7.7Quality: 5.0
Piotroski: 4/9Altman Z: 0.76

VUZI

Avoid

16

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: -11.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DCBOUndervalued (+72.2%)

Margin of Safety

+72.2%

Fair Value

$67.89

Current Price

$17.21

$50.68 discount

UndervaluedFair: $67.89Overvalued
VUZIUndervalued (+40.5%)

Margin of Safety

+40.5%

Fair Value

$4.15

Current Price

$4.23

$0.08 discount

UndervaluedFair: $4.15Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DCBO4 strengths · Avg: 9.5/10
Return on EquityProfitability
132.9%10/10

Every $100 of equity generates 133 in profit

EPS GrowthGrowth
141.7%10/10

Earnings expanding 141.7% YoY

Debt/EquityHealth
-136.0410/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.2x8/10

Attractively priced relative to earnings

VUZI1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Areas to Watch

DCBO3 concerns · Avg: 2.0/10
Market CapQuality
$449.78M3/10

Smaller company, higher risk/reward

Altman Z-ScoreHealth
0.762/10

Distress zone — elevated risk

Operating MarginProfitability
-0.1%1/10

Operating margin of -0.1%

VUZI4 concerns · Avg: 3.5/10
Price/BookValuation
14.1x4/10

Trading at 14.1x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$259.45M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : DCBO

The strongest argument for DCBO centers on Return on Equity, EPS Growth, Debt/Equity. Revenue growth of 14.5% demonstrates continued momentum.

Bull Case : VUZI

The strongest argument for VUZI centers on Debt/Equity.

Bear Case : DCBO

The primary concerns for DCBO are Market Cap, Altman Z-Score, Operating Margin.

Bear Case : VUZI

The primary concerns for VUZI are Price/Book, EPS Growth, Market Cap.

Key Dynamics to Monitor

VUZI carries more volatility with a beta of 1.69 — expect wider price swings.

DCBO is growing revenue faster at 14.5% — sustainability is the question.

DCBO generates stronger free cash flow (24M), providing more financial flexibility.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DCBO scores higher overall (51/100 vs 16/100) and 14.5% revenue growth. VUZI offers better value entry with a 40.5% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Docebo Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Docebo Inc. provides a cloud-based learning management system to train internal and external workforce, partners, and customers in North America, Europe, and the Asia-Pacific region. The company is headquartered in Toronto, Canada.

Visit Website →

Vuzix Corp Cmn Stk

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Vuzix Corporation designs, manufactures, markets and sells augmented reality (AR) computing and display devices for consumer and business markets in North America, Asia-Pacific, Europe, and internationally. The company is headquartered in West Henrietta, New York.

Want to dig deeper into these stocks?